by The global virology market size was estimated to be around US$ 2.6 billion in 2022. It is projected to reach US$ 4.26 billion by 2032, indicating a CAGR of 5.10% from 2023 to 2032.
Key Takeaways
- North America led the market with the biggest market share of 38% in 2022.
- Asia-Pacific is projected to expand at the fastest CAGR during the forecast period.
- By Product Type, the antiviral therapeutics segment has held the largest revenue share of 45% in 2022.
- By Product Type, the interferons segment is anticipated to grow at a notable CAGR of 6.7% during the projected period.
- By Application, the respiratory tract infections segment contributed more than 36% of revenue share in 2022.
- By Application, the eye infections segment is estimated to expand at the fastest CAGR over the projected period.
- By End User, the hospitals segment has held the largest revenue share 30% in 2022.
- By End User, the diagnostic centers segment is expected to grow at a CAGR of 7.9% over the predicted period.
Virology Market Overview
The Virology Market is a dynamic sector within the broader field of medical science dedicated to the study of viruses and viral diseases. With a relentless pursuit of understanding, diagnosing, and treating viral infections, the Virology Market plays a pivotal role in global healthcare.
Get a Sample: https://www.precedenceresearch.com/sample/3428
Virology Market Scope
| Report Coverage | Details |
| Growth Rate from 2023 to 2032 | CAGR of 5.10% |
| Market Size in 2023 | USD 2.72 Billion |
| Market Size by 2032 | USD 4.26 Billion |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product Type, By Application, and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Pipettes Market Size to Garner USD 2.04 Billion by 2032
Growth Factors
Several key factors contribute to the continuous growth of the Virology Market. Technological advancements, particularly in molecular diagnostics and genomics, have revolutionized virus detection and research methodologies. The increasing prevalence of viral infections, coupled with a growing global population and international travel, drives the demand for effective virological diagnostics and therapeutics. Additionally, the ongoing efforts in vaccine development and the heightened awareness of emerging infectious diseases further stimulate the market’s expansion.
Focusing on the global Virology market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the Virology market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.
Region Snapshot
The Virology Market exhibits variations and opportunities across different regions. North America stands at the forefront, driven by substantial investments in research and development, a robust healthcare infrastructure, and a proactive approach to viral outbreaks. Europe follows closely, with a focus on collaborative efforts in virological research and a high level of healthcare accessibility.
The Asia-Pacific region is experiencing significant growth, propelled by the rising incidence of viral diseases and increasing healthcare expenditure. These regional dynamics collectively contribute to the global landscape of the Virology Market, shaping its trajectory in the coming years.
Recent Developments
- In May 2022, QuantuMDx Group Limited introduced its latest respiratory panel test, the Q-POC SARS-CoV-2, Flu A/B & RSV Assay. This innovative assay is designed to operate on the Q-POC platform, which boasts multiplex capabilities. This advancement enables users to conduct swift point-of-care testing in various settings, whether clinical or non-clinical.
- In January 2022, InTec made headlines with the unveiling of its novel and highly sensitive SARS-CoV-2 Rapid Antigen Test, known as the AQ+ Covid-19 Ag Rapid Test. Specifically developed for professional use, this test empowers healthcare professionals and even laypersons to swiftly and conveniently identify COVID-19 cases.
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Virology Market Players
- GlaxoSmithKline plc
- Abbott Laboratories
- Boehringer Ingelheim Corporation
- Merck and Co. Inc.
- Novartis International AG
- Siemens
- Johnson & Johnson
- AstraZeneca AB
- Roche
- Trinity Biotech
Virology Market Segmentations
By Product Type
- Diagnosing Test
- Viral Infection Controlling Methods
- Antiviral Chemotherapy
- Interferons
By Application
- Skin and Soft Tissue Infections
- Respiratory Tract Infections
- GI Tract Infections
- Urinary Tract Infections
- Eye Infections
- CNS Infections
- Sexually Transmitted Diseases
- Perinatal Infections
By End User
- Hospitals
- Clinics
- Laboratories
- Diagnostic Centers
- Blood Banks
- Pharmacies
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Virology Market
5.1. COVID-19 Landscape: Virology Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Virology Market, By Product Type
8.1. Virology Market, by Product Type, 2023-2032
8.1.1 Diagnosing Test
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Viral Infection Controlling Methods
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Antiviral Chemotherapy
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Interferons
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Virology Market, By Application
9.1. Virology Market, by Application, 2023-2032
9.1.1. Skin and Soft Tissue Infections
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Respiratory Tract Infections
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. GI Tract Infections
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Urinary Tract Infections
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Eye Infections
9.1.5.1. Market Revenue and Forecast (2020-2032)
9.1.6. Sexually Transmitted Diseases
9.1.6.1. Market Revenue and Forecast (2020-2032)
9.1.7. Perinatal Infections
9.1.7.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Virology Market, By End User
10.1. Virology Market, by End User, 2023-2032
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Clinics
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Laboratories
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Diagnostic Centers
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Blood Banks
10.1.5.1. Market Revenue and Forecast (2020-2032)
10.1.6. Pharmacies
10.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Virology Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.1.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.3. Market Revenue and Forecast, by End User (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.2.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.3. Market Revenue and Forecast, by End User (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.6.3. Market Revenue and Forecast, by End User (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.7.3. Market Revenue and Forecast, by End User (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.3.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.3. Market Revenue and Forecast, by End User (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.6.3. Market Revenue and Forecast, by End User (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.7.3. Market Revenue and Forecast, by End User (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.6.3. Market Revenue and Forecast, by End User (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.7.3. Market Revenue and Forecast, by End User (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.5.3. Market Revenue and Forecast, by End User (2020-2032)
Chapter 12. Company Profiles
12.1. GlaxoSmithKline plc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Abbott Laboratories
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Boehringer Ingelheim Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Merck and Co. Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Novartis International AG
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Siemens
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Johnson & Johnson
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. AstraZeneca AB
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Roche
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Trinity Biotech
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
